• Cholera
  • Travel Vaccines

The package insert for the oral cholera vaccine CVD 103-HgR (Vaxchora, Emergent BioSolutions) states that effectiveness and safety have not been established for revaccination. Does ACIP have any recommendations on revaccination?

ACIP has not made recommendation related to revaccination or booster doses with the FDA-licensed oral cholera vaccine, CVD 103-HgR. As more information becomes available, CDC will update its recommendations accordingly.

Last reviewed: August 21, 2023

This page was updated on .